Invesco Biotechnology & Genome ETF | |
$ 67.27 | |
Last Holding update 2024-09-27 | 30 Stocks (6 new) |
Value $270.00 Mil | Turnover 22 % |
Portfolio Report | |
Registrant: Invesco Biotechnology & Genome ETF
|
Performance
Annualized Return %
Total Annual Return %
Key Statistics
Name | Value | ||
---|---|---|---|
Day's Open ($) | 67.93 | ||
Day's Range ($) | 67.11 - 67.9899 | ||
Day's Volume | 2,833 | ||
52-Week Range ($) | 52.47 - 72.72 | ||
Beta | 0.78 | ||
Volatility | 20.51 | ||
14-Day RSI | 38.83 | ||
14-Day ATR ($) | 0.847643 | ||
20-Day SMA ($) | 69.077955 |
Fundamental Data
Name | Value | ||
---|---|---|---|
Market Cap (Mil $) | 254.281 | ||
Shares Outstanding (Mil) | 3.78 | ||
PE Ratio | 27.27 | ||
PE Ratio (10y Range) | 14.2 - 35.8 | ||
PE Ratio (10y Median) | 21.2 | ||
PB Ratio | 3.82 | ||
PB Ratio (10y Range) | 2.94 - 5.95 | ||
PB Ratio (10y Median) | 4.16 |
Dividend Data
Name | Value | ||
---|---|---|---|
Dividends per Share (TTM) ($) | 0.065 | ||
Dividend Yield % | 0.1 | ||
Dividend Yield % (10y Range) | 0.01 - 1.84 | ||
Dividend Yield % (10y Median) | 0.1 | ||
Next Dividend Payment Date | |||
Dividend Frequency | Quarterly |
PBE Invesco Biotechnology & Genome ETF Fundamental Charts
Historical TTM Price-to-Earnings for PBE Invesco Biotechnology & Genome ETF
Historical TTM Price-to-Earnings without NRI for PBE Invesco Biotechnology & Genome ETF
Historical Price-to-Book Ratio for PBE Invesco Biotechnology & Genome ETF
Historical Dividend Yields for PBE Invesco Biotechnology & Genome ETF
PBE Invesco Biotechnology & Genome ETF Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with ARCA:PBE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ARCA:PBE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Invesco Biotechnology & Genome... Top Holdings of 2024-07-31
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ILMN | Illumina Inc | 118,985 | 14587.560 | New Holding | 5.400 | +5.40% | 0.070 | +21.58% | +4.47% | 22523.427 | Medical Diagnostics & Research | |
GILD | Gilead Sciences Inc | 190,532 | 14491.860 | +6.09% | 5.370 | +0.31% | 0.020 | +21.92% | +13.12% | 110530.396 | Drug Manufacturers | |
INCY | Incyte Corp | 212,794 | 13846.510 | New Holding | 5.130 | +5.13% | 0.110 | -2.50% | +3.90% | 12565.092 | Biotechnology | |
BMRN | Biomarin Pharmaceutical Inc | 163,681 | 13803.220 | +12.18% | 5.110 | +0.55% | 0.090 | -16.83% | -27.00% | 13401.047 | Biotechnology | |
VRTX | Vertex Pharmaceuticals Inc | 27,259 | 13512.830 | -11.38% | 5.000 | -0.56% | 0.010 | -3.85% | +15.98% | 121801.010 | Biotechnology | |
REGN | Regeneron Pharmaceuticals Inc | 12,513 | 13503.900 | -8.43% | 5.000 | -0.42% | 0.010 | -12.44% | +5.76% | 102396.854 | Biotechnology | |
AMGN | Amgen Inc | 40,588 | 13494.290 | -11.06% | 5.000 | -0.56% | 0.010 | -5.28% | +12.02% | 169629.460 | Drug Manufacturers | |
NBIX | Neurocrine Biosciences Inc | 86,725 | 12277.660 | -11.08% | 4.550 | -0.60% | 0.090 | -20.81% | -12.33% | 11664.776 | Drug Manufacturers | |
IONS | Ionis Pharmaceuticals Inc | 176,538 | 8731.570 | +10.94% | 3.230 | +0.32% | 0.110 | -23.59% | -23.36% | 6114.457 | Biotechnology | |
HALO | Halozyme Therapeutics Inc | 154,246 | 8523.630 | -21.32% | 3.160 | -0.65% | 0.120 | -10.61% | +33.39% | 6245.239 | Biotechnology |
Invesco Biotechnology & Genome ETF's Historical Top Holdings Breakdowns
Invesco Biotechnology & Genome ETF's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
ILMN | Illumina Inc | 2024-07-31 | New Buy | +5.40% | 98.22 ($109.76) 125.23 | $141.39 | 28.82% | New holding | 118,985 | 118,985 | |
BIIB | Biogen Inc | 2024-07-31 | Sold Out | -5.15% | 211.17 ($225.35) 236.8 | $183.86 | -18.41% | Sold Out | 0 | -59,022 | |
INCY | Incyte Corp | 2024-07-31 | New Buy | +5.13% | 53.06 ($60.28) 68.61 | $65.24 | 8.23% | New holding | 212,794 | 212,794 | |
IRWD | Ironwood Pharmaceuticals Inc | 2024-07-31 | New Buy | +2.86% | 5.58 ($6.58) 8.3 | $3.98 | -39.51% | New holding | 1,130,122 | 1,130,122 | |
CLDX | Celldex Therapeutics Inc | 2024-07-31 | Sold Out | -2.79% | 32.76 ($37.6) 44.56 | $28.13 | -25.19% | Sold Out | 0 | -183,305 | |
TECH | Bio-Techne Corp | 2024-07-31 | Reduce | -2.58% | 71.24 ($77.31) 84.15 | $68.37 | -11.56% | Reduce -54.5% | 83,707 | -100,258 | |
OPK | OPKO Health Inc | 2024-07-31 | New Buy | +2.57% | 1.21 ($1.33) 1.52 | $1.40 | 5.26% | New holding | 4,886,099 | 4,886,099 | |
XENE | Xenon Pharmaceuticals Inc | 2024-07-31 | Sold Out | -2.41% | 36.12 ($39.87) 43.96 | $41.85 | 4.97% | Sold Out | 0 | -145,751 | |
SAGE | Sage Therapeutics Inc | 2024-07-31 | New Buy | +2.26% | 10.38 ($11.5) 13.94 | $7.85 | -31.74% | New holding | 557,004 | 557,004 | |
XNCR | Xencor Inc | 2024-07-31 | New Buy | +2.15% | 18.18 ($21.24) 24.5 | $21.16 | -0.38% | New holding | 283,973 | 283,973 |
Invesco Biotechnology & Genome ETF Total Holding History ($B)
Invesco Biotechnology & Genome ETF's Asset Allocation
Invesco Biotechnology & Genome ETF Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
Invesco Biotechnology & Genome ETF's Hypothetical Growth since 2024-07-31
Invesco Biotechnology & Genome ETF's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
Invesco Biotechnology & Genome ETF's Holdings Heat Map
Size field:
Invesco Biotechnology & Genome ETF's Holdings Bubble Chart
Invesco Biotechnology & Genome ETF News
- 1